awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36663677-F656A68B-143B-429B-AA90-0356AC8C3032
Q36663677-F656A68B-143B-429B-AA90-0356AC8C3032
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36663677-F656A68B-143B-429B-AA90-0356AC8C3032
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer
P2860
Q36663677-F656A68B-143B-429B-AA90-0356AC8C3032
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36663677-F656A68B-143B-429B-AA90-0356AC8C3032
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c0d8dbea4ec76ea472735062007517d5c7982871
P2860
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.